Role of Siddha medicine in the management of radiotherapy induced oral complications in cancer patients- an observational study

Role of Siddha medicine in the management of radiotherapy induced oral complications in cancer patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2019/05/018888

Enrollment

Registered

2019-05-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cancer patients with past history of radiotherapy within past 1 year 2.Patients having oral complications of radiotherapy 3.Patients willing to participate in study

Exclusion criteria

Exclusion criteria: 1.Patients treated with other modalities of cancer treatment 2.Patients not willing to participate in this study

Design outcomes

Primary

Measure	Time frame
To observe the role of Siddha medicines in the management of radiotherapy induced oral complications in cancer patientsTimepoint: 6 months	—

Secondary

Measure	Time frame
To observe improvement in xerostomia before and after treatment To observe taste acquity before and after treatmentTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDr B NEETHI

National Institute of Siddha

ss.drss@gmail.com8939138936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026